Please wait

.2

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Voting Common Stock, par value $0.0001 per share, of Jasper Therapeutics, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Dated: September 23, 2025

  Velan Capital Master Fund LP
   
  By: Velan Capital Holdings LLC
General Partner
   
  By:

/s/ Adam Morgan

    Name: Adam Morgan
    Title: Managing Member

 

 

  Velan Capital Holdings LLC
     
  By:

/s/ Adam Morgan

    Name: Adam Morgan
    Title: Managing Member

 

 

  Velan Horizon Fund LP
   
  By:

Velan Horizon GP LLC

General Partner

   
  By:

/s/ Adam Morgan

    Name: Adam Morgan
    Title: Managing Member

 

 

  Velan Horizon GP LLC
   
  By:

/s/ Adam Morgan

    Name: Adam Morgan
    Title: Managing Member

 

 

 

 

  Velan Capital Investment Management LP
   
  By: Velan Capital Management LLC
General Partner
   
  By:

/s/ Adam Morgan

    Name: Adam Morgan
    Title: Managing Member

 

 

  Velan Capital Management LLC
   
  By:

/s/ Adam Morgan

    Name: Adam Morgan
    Title: Managing Member

 

 

  Avego Healthcare Capital, L.P.
   
  By: Avego Healthcare Capital Holdings, LLC
General Partner
   
  By:

/s/ Balaji Venkataraman

    Name: Balaji Venkataraman
    Title: Managing Member

 

 

  Avego Healthcare Capital Holdings, LLC
     
  By:

/s/ Balaji Venkataraman

    Name: Balaji Venkataraman
    Title: Managing Member

 

 

  Avego Management, LLC
     
  By:

/s/ Balaji Venkataraman

    Name: Balaji Venkataraman
    Title: Managing Member

 

 

 

/s/ Adam Morgan

  Adam Morgan

 

 

 

/s/ Balaji Venkataraman

  Balaji Venkataraman

 

 

 

/s/ Vishal Kapoor

  Vishal Kapoor